General
Australian managing partner of McKinsey regrets consultancy’s role during opioid epidemic
A damaging exposé has revealed how international consulting firm McKinsey & Company tried to pump up sales of an addictive painkiller during the opioid epidemic.
Key points:
- Consultancy firm McKinsey advised Purdue Pharma on how to increase the market share of its painkiller, OxyContin, at the height of the opioid crisis
- Its advice included offering rebates for OxyContin overdoses
- A McKinsey Australia spokesperson acknowledged a Zoom meeting was held after the revelations, saying it was part of a commitment to consider broader societal impacts of the firm’s work
After the news broke in The New York Times, the firm was in damage control and it sought to explain itself to its Australian workforce.
On a Monday earlier this month, Australian…
Continue Reading
-
Noosa News17 hours agoTammy Hembrow’s half-brother walks free after choking and stalking ex-girlfriend
-
Noosa News22 hours agoPolice hunt two after baby girl sprayed with stolen fire extinguisher in Sippy Downs
-
Business18 hours agoHow to start investing in ASX shares with just $1,000
-
Business17 hours agoGuess which ASX 300 stock was downgraded to sell today